Top Markets
#1 Wibx Wibx +3.22%
#2 BOT BOT +2.51%
#3 TronBank TronBank +2.45%
#4 Cysic Cysic +2.29%
#5 Starpower Starpower +2.10%
#6 Wiki Cat Wiki Cat +2.02%
#7 The Bitcoin Bull The Bitcoin Bull +1.56%
#8 Tokamak Network Tokamak Network +1.53%
#9 Audiera Audiera +1.45%
#10 SIXSEVEN SIXSEVEN +1.17%
Coin of the day
Wibx Wibx
Settings
Language
ENGLISH
Currency
USD
Theme
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Rank in Stocks #32811
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Share Price
$2.22
Last synced: 2026-08-17
Market Cap
$9.03M
Change (1 day)
-3.13%
Change (1 year)
-24.26%
Country
JP
Trade PhoenixBio Co., Ltd. (6190)

Category

Healthcare
Number of shares outstanding for PhoenixBio Co., Ltd. (6190)
Number of shares outstanding as of August 2026: 0
According to PhoenixBio Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for PhoenixBio Co., Ltd. (6190) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE